OCT 28, 2014 08:00 AM PDT

The identification of single nucleotide and structural variants in gene sequencing

Speakers
  • Max van Min, CEO, CergentisLaurel Provencher, Manager of Assay Development, PerkinElmer
    Biography
      Max van Min is CEO of Cergentis and co-inventor of its Targeted Locus Amplification (TLA) Technology. Max received a Master of Science degree in Biotechnology from Wageningen University & Research Centre in the Netherlands and has a career in commercial management positions in the Life Sciences.
       
      Laurel is a Manager of Assay Development in the Microfluidics and Automation business unit of the Life Sciences and Technology division of PerkinElmer, Inc.  In the past ten years, Laurel has led various assay development projects including standardized automated NGS sample prep workflows, microfluidic analysis of DNA and protein samples, and microfluidic mobility-shift assays for drug discovery.  Her experience has included numerous collaborative projects in genomics, biotherapeutics and  small molecule drug development projects.

    Abstract:
    The TLA Technology constitutes a paradigm shift in targeted next generation sequencing (NGS). The TLA technology uses the physical proximity of nucleotides within a locus of interest as the basis of selection. DNA is cross-linked, fragmented and ligated. Only one to a few primer pairs specific for a genetic locus of interest are in-turn required for the amplification of an entire locus. TLA  enrichment in combination with NGS is a very flexible and easy approach to sequence regions of interest and identify all single nucleotide variants (SNV's) and structural variants including comprehensive gene-fusion sequencing and the characterization of transgenes and their integration sites. Implementation of automated sample prep and QC for TLA technology will be discussed with an overview of liquid handling and microfluidic solutions for increasing productivity in NGS sample prep workflows.

    Show Resources
    You May Also Like
    OCT 02, 2019 11:00 AM PDT
    OCT 02, 2019 11:00 AM PDT
    DATE: October 2, 2019TIME: 11:00am PDT, 2:00pm EDT Ditch the Excel spreadsheets and manage your molecular workflows entirely in your LIMS Achieve configuration of molecular workf...
    SEP 05, 2019 04:00 PM CEST
    C.E. CREDITS
    SEP 05, 2019 04:00 PM CEST
    DATE: September 5, 2019TIME: 7:00am PT, 10:00am ET, 4:00pm CEST PCR (Polymerase Chain Reaction) has gone through a massive evolution since its development in 1983. Besides it...
    JUN 05, 2019 05:00 PM CEST
    C.E. CREDITS
    JUN 05, 2019 05:00 PM CEST
    DATE: June 5, 2019TIME: 8:00am PDT, 11:00am EDT, 5:00pm CEST Eukaryotic cell cultures respond to the most subtle influence. Apart from the risk of contamination, minimal chan...
    AUG 27, 2019 09:00 AM PDT
    C.E. CREDITS
    AUG 27, 2019 09:00 AM PDT
    DATE: August 27, 2019 TIME: 9:00am PDT, 12:00pm EDT Immunotherapies targeting PD-1 or PD-L1 have proven remarkably effective for treating cancer in some patients, with considerabl...
    MAY 16, 2019 04:00 PM CEST
    C.E. CREDITS
    MAY 16, 2019 04:00 PM CEST
    DATE: May 16, 2019TIME: 7:00am PDT, 10:00am EDT, 4:00pm CEST The emergence of NGS is revolutionizing the microbiological sciences and transforming medicine. Deep sequencing has...
    NOV 18, 2019 07:00 AM PST
    Add to Calendar Select one of the following: iCal Google Calendar Outlook Calendar Yahoo Calendar
    C.E. CREDITS
    NOV 18, 2019 07:00 AM PST
    Add to Calendar Select one of the following: iCal Google Calendar Outlook Calendar Yahoo Calendar
    DATE: November 18, 2019TIME: 7:00am PST, 11:00am EST, 4:00pm CEWT How often do you pipette in your cell culture lab every day? Usually, we do it so often that we tend stop th...
    Loading Comments...
    Show Resources